SS
GCTK icon

SBI Securities’s GlucoTrack GCTK Stock Holding History

SBI Securities’s Portfolio GCTK Stock Details GCTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6 Hold
9
– – ﹤0.01% 3895
2025
Q4 		$35 Hold
9
– – ﹤0.01% 3650
2025
Q3 		$59 Sell
9
-1
-10% -$6 ﹤0.01% 3665
2025
Q2 		$60 Buy
+10
New +$88 ﹤0.01% 3680
2025
Q1 		– Hold
0
– – – 4063
2024
Q4 		– Hold
0
– – – 4036

Other funds holding GCTK

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
AF
Alerus Financial Grand Forks, North Dakota $2.02B AUM 26.03% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SBI Securities's GCTK Position: Q1 2026 in Review

SBI Securities held its GlucoTrack (GCTK) position steady in Q1 2026 at 9 shares worth $6. The position accounts for ﹤0.01% of the portfolio, ranked #3895.

SBI Securities first reported a position in GCTK in Q2 2025 and has held it in 4 quarters since. The position peaked at $60 in Q2 2025. 13 funds tracked by Wall St. Rank hold GCTK as of Q1 2026.

  • SBI Securities held 9 shares of GlucoTrack worth $6 as of Q1 2026.
  • SBI Securities left its GlucoTrack share count unchanged in Q1 2026.
  • GlucoTrack made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #3895 holding.
  • SBI Securities first reported a position in GlucoTrack in Q2 2025 and has held it in 4 quarters since.
  • SBI Securities's GlucoTrack position peaked at $60 in Q2 2025.
  • 13 funds tracked by Wall St. Rank held GlucoTrack as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.